Elan Corporation PLC, Biogen Idec, Inc. (Massachusetts) Tysabri Reports 10 More Brain Disease Cases

Irish Examiner -- THE owners of multiple sclerosis drug Tysabri have reported a further 10 cases of the rare brain disease PML as a side-effect of using the treatment.

MORE ON THIS TOPIC